These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8203395)

  • 1. Clinical interventions reduce antimicrobial costs.
    Rao S; Machuga D
    Am J Hosp Pharm; 1994 Mar; 51(5):703. PubMed ID: 8203395
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving budget control: a case study.
    Karali J
    Hosp Cost Manag Account; 1993 May; 5(2):1-8. PubMed ID: 10125473
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacy. Target drug programs can reduce some costs and avoid others.
    Cost Containment; 1984 Aug; 6(16):3-6. PubMed ID: 10267698
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost benefit of pharmacy audit and nonrestrictive antibiotic policy.
    Ware GJ; Ford DJ
    N Z Med J; 1993 Apr; 106(954):160. PubMed ID: 8479665
    [No Abstract]   [Full Text] [Related]  

  • 7. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 8. Can extended dosing intervals reduce drug costs while maintaining patient care?
    Tse CS; Madura AJ
    Hosp Formul; 1993 Jul; 28(7):648-50. PubMed ID: 10127047
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring antibiotic prescriptions can reduce use and cost of drugs.
    Douglas AS
    Mod Healthc; 1984 Oct; 14(13):106-7. PubMed ID: 10268397
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
    Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
    Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic cost control measures in a hospital pharmacy.
    Manzo J; Amodio-Groton MA; Kleinmann K
    Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowing rate of cost increases in the pharmacy.
    Roark M
    Hospitals; 1993 Jan; 67(2):56. PubMed ID: 8419282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug cost containment in the hospital.
    Smith WE
    Hosp Formul; 1978 Sep; 13(9):695-8. PubMed ID: 10238490
    [No Abstract]   [Full Text] [Related]  

  • 17. Involving physicians in efforts to control pharmaceutical expenditures.
    Shulkin DJ; McGourty ME; Bourret J
    Med Interface; 1995 Aug; 8(8):85-7, 90. PubMed ID: 10144777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT; Nakagawa RS
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the costs of antibiotic resistance.
    North D
    Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephalosporin cost reduction.
    Martucci HJ; Parry MF
    Hosp Formul; 1981 Apr; 16(4):396-8, 403. PubMed ID: 10250718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.